statproginc12.bsky.social
@statproginc12.bsky.social
Sentient AIoT and Fixed Wireless Access Set to Force a 'Great IoT Re-alignment' in 2026 - buff.ly/qyNtFZP #iot #realignment #2026 #aiot
Sentient AIoT and Fixed Wireless Access Set to Force a 'Great IoT Re-alignment' in 2026 | IoT For All
New Global Predictions from Eseye Forecasts the Dawn of Sentient AIoT
buff.ly
December 15, 2025 at 2:15 PM
Smart Farming with IoT and AI: Precision Weed Control for a Sustainable Future - buff.ly/J4jTwCR #iot #smartfarming #sustainable
Smart Farming with IoT and AI: Precision Weed Control for a Sustainable Future | IoT For All
AI and IoT drive Nordic smart farming, enabling precision weed control, higher yields, and reduced chemical use for sustainable agriculture.
buff.ly
December 12, 2025 at 2:15 PM
Python 3.14.1 arrives with a pile of improvements - ift.tt/GfKPeha #python #update #programming
Python 3.14.1 arrives with a pile of improvements
Fixing a lot of bugs.
ift.tt
December 9, 2025 at 2:15 PM
OpenAI says hackers stole data from its analytics partner — but no ChatGPT users were affected - buff.ly/aWBpROg #data #analytics #artificialintelligence #businessintelligence #openai
OpenAI says hackers stole data from its analytics partner
The data stolen via Mixpanel could include "limited analytics data" such as names, email addresses, and approximate location for some API users.
buff.ly
December 4, 2025 at 2:15 PM
Why developers still flock to Python: Guido van Rossum on readability, AI, and the future of programming - buff.ly/9CAjCer #python #programming #developers #vanrossum
Why developers still flock to Python: Guido van Rossum on readability, AI, and the future of programming
Discover how Python changed developer culture—and see why it keeps evolving.
buff.ly
December 2, 2025 at 2:15 PM
Game changer for kidney transplant patients: UCLA clinical trial could eliminate need for lifelong immunosuppressive drugs - buff.ly/GDN8vNn #clinicaltrial #clinicaltrials #transplant #kidney #kidneytransplant
Game changer for kidney transplant patients: UCLA clinical trial could eliminate need for lifelong immunosuppressive drugs
A $6.7 million grant from the California Institute for Regenerative Medicine will support UCLA’s clinical trial of a stem cell-based therapy that aims to help kidney transplant patients safely stop…
buff.ly
December 1, 2025 at 8:15 PM